PATENT CLAIM ANALYSIS

Application Number: 15781303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "210160"]

Abstract:
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Claim (Index 5):
The compound of  claim 4  wherein (when present):\n R 1a  is selected from fluoro, chloro, hydroxyl, methyl, difluoromethyl, amino, methoxy or 1H-pyrazolyl or 1H-imidazol-1-yl, \n wherein 1H-pyrazolyl is optionally substituted with 1 or 2 substituents each selected from R 3a ; \n R 3a  is selected from nitro or methyl or amino; and, \n R 4a  is methyl or ethyl; \n R 5a  is hydrogen or methyl; \n wherein a form of the compound is selected from the group consisting of a prodrug, salt, hydrate, solvate, clathrate, isotopologue, racemate, enantiomer, diastereomer, stereoisomer, polymorph and tautomer form thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 2.23529
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14160180', '14242282', '13812366', '13653192', '14363051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7981907500800631
- 35 USC 102 Novelty (BERT): 0.5300622972199065
- Combined Prediction Score: 0.7713779047940474
- Mean Citation Score: 296.341898
- Max Citation Score: 358.8583
- Similarity Product: 269.8653680500388

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test